Pay in 4 interest-free payments of $6.15 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
doi: 10.1210/en.2009-0517
requires medical knowledge to minimize risk Intranasal Intranasal delivery to target the olfactory bulb and trans-cribriform access to the brain has been explored for some peptides: Theoretical advantage: Direct CNS access, bypassing the blood-brain barrier Reality: Intranasal peptide formulations are complex and Dihexa is not commonly available in this form Evidence: No published data on intranasal Dihexa efficacy or safety Oral Bioavailability: Approximately 38% The most commonly cited bioavailability figure for oral Dihexa is approximately 38%
Chromium Picolinate leads to a healthy carbohydrate metabolism
Professional Supervision: Unlike over-the-counter products, our treatment is fully supervised by Jonathan Sykes and his expert team, ensuring safety and consistency
To Book Appointment
